Mechanism-based inhibitors of glycosidases: design and applications.

This article covers recent developments in the design and application of activity-based probes (ABPs) for glycosidases, with emphasis on the different enzymes involved in metabolism of glucosylceramide in humans. Described are the various catalytic reaction mechanisms employed by inverting and retaining glycosidases. An understanding of catalysis at the molecular level has stimulated the design of different types of ABPs for glycosidases. Such compounds range from (1) transition-state mimics tagged with reactive moieties, which associate with the target active site—forming covalent bonds in a relatively nonspecific manner in or near the catalytic pocket—to (2) enzyme substrates that exploit the catalytic mechanism of retaining glycosidase targets to release a highly reactive species within the active site of the enzyme, to (3) probes based on mechanism-based, covalent, and irreversible glycosidase inhibitors. Some applications in biochemical and biological research of the activity-based glycosidase probes are discussed, including specific quantitative visualization of active enzyme molecules in vitro and in vivo, and as strategies for unambiguously identifying catalytic residues in glycosidases in vitro.

[1]  G. Liang,et al.  Multifunctional fluorescent probe for sequential detections of glutathione and caspase-3 in vitro and in cells. , 2013, Analytical chemistry.

[2]  H. Overkleeft,et al.  Tuning the leaving group in 2-deoxy-2-fluoroglucoside results in improved activity-based retaining β-glucosidase probes. , 2012, Chemical communications.

[3]  G. Semenza,et al.  Stereospecific ring opening of conduritol-B-epoxide by an active site asparatate residue of sucrase-isomaltase. , 1977, Biochimica et biophysica acta.

[4]  S. Withers,et al.  Detailed comparative analysis of the catalytic mechanisms of beta-N-acetylglucosaminidases from families 3 and 20 of glycoside hydrolases. , 2005, Biochemistry.

[5]  R. Brady,et al.  Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease , 2004, Journal of Inherited Metabolic Disease.

[6]  P. Stahl,et al.  Identification of the macrophage mannose receptor as a 175-kDa membrane protein. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. B. Kempton,et al.  Unequivocal demonstration of the involvement of a glutamate residue as a nucleophile in the mechanism of a retaining glycosidase , 1990 .

[8]  G. Legler Untersuchungen zum Wirkungsmechanismus glykosidspaltender Enzyme, I. Darstellung und Eigenschaften spezifischer Inaktivatoren , 1966 .

[9]  G. Piccialli,et al.  Identification of the active site nucleophile in the thermostable beta-glycosidase from the archaeon Sulfolobus solfataricus expressed in Escherichia coli. , 1997, Biochemistry.

[10]  M. Sinnott,et al.  Kinetic Isotope Effect Study of Transition States for the Hydrolyses of .alpha.- and .beta.-Glucopyranosyl Fluorides , 1994 .

[11]  G. Legler,et al.  Active site‐directed inhibition of galactosidases by conduritol C epoxides (1,2‐anhydro‐EPI‐and NEO‐inositol , 1981, FEBS letters.

[12]  Jian‐Qiang Fan A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity. , 2003, Trends in pharmacological sciences.

[13]  S. Withers,et al.  Identification of Glu340 as the active-site nucleophile in human glucocerebrosidase by use of electrospray tandem mass spectrometry. , 1994, The Journal of biological chemistry.

[14]  G. Davies,et al.  Structure of the endoglucanase I from Fusarium oxysporum: native, cellobiose, and 3,4-epoxybutyl beta-D-cellobioside-inhibited forms, at 2.3 A resolution. , 1997, Biochemistry.

[15]  C. Klein,et al.  CD40 stimulation sensitizes CLL cells to lysosomal cell death induction by type II anti-CD20 mAb GA101. , 2011, Blood.

[16]  Matthew S Macauley,et al.  Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. , 2012, Nature chemical biology.

[17]  H. Mori,et al.  A Catalytic Amino Acid and Primary Structure of Active Site in Aspergillus niger α-Glucosidase , 1997 .

[18]  William S York,et al.  Regulation of Glycan Structures in Animal Tissues , 2008, Journal of Biological Chemistry.

[19]  J. Kuiper,et al.  Correction of Liver Steatosis by a Hydrophobic Iminosugar Modulating Glycosphingolipids Metabolism , 2012, PloS one.

[20]  E. Beutler,et al.  Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Scheule,et al.  Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann-Pick C mice. , 2012, Molecular genetics and metabolism.

[22]  Daniel E. Koshland,et al.  STEREOCHEMISTRY AND THE MECHANISM OF ENZYMATIC REACTIONS , 1953 .

[23]  S. Withers,et al.  Trapping and characterization of the reaction intermediate in cyclodextrin glycosyltransferase by use of activated substrates and a mutant enzyme. , 1997, Biochemistry.

[24]  E. Chargaff,et al.  A reinvestigation of the cerebroside deposited in Gaucher's disease. , 1958, The Journal of biological chemistry.

[25]  S. Sonnino,et al.  Membrane domains and the "lipid raft" concept. , 2012, Current medicinal chemistry.

[26]  S. Withers,et al.  Identification of Glu-120 as the catalytic nucleophile in Streptomyces lividans endoglucanase celB. , 1998, The Biochemical journal.

[27]  H. Sjöström,et al.  Purification and characterisation of amphiphilic lactase/phlorizin hydrolase from human small intestine. , 1981, European journal of biochemistry.

[28]  V. Tiwari,et al.  Carbohydrate based potential chemotherapeutic agents: recent developments and their scope in future drug discovery. , 2012, Mini reviews in medicinal chemistry.

[29]  Rosemarie E. Venier,et al.  Miglustat as a therapeutic agent: prospects and caveats , 2012, Journal of Medical Genetics.

[30]  N. Sharon,et al.  Identification of aspartic acid 52 as the point of attachment of an affinity label in hen egg white lysozyme. , 1973, The Journal of biological chemistry.

[31]  S. Withers,et al.  Mechanism of action and identification of Asp242 as the catalytic nucleophile of Vibrio furnisii N-acetyl-beta-D-glucosaminidase using 2-acetamido-2-deoxy-5-fluoro-alpha-L-idopyranosyl fluoride. , 2000, Biochemistry.

[32]  J. Sussman,et al.  Characterization of gene-activated human acid-β-glucosidase: Crystal structure, glycan composition, and internalization into macrophages , 2009, Glycobiology.

[33]  S. Brul,et al.  Efficient routing of glucocerebrosidase to lysosomes requires complex oligosaccharide chain formation. , 1986, Biochemical and biophysical research communications.

[34]  Z. Shuzheng,et al.  Inactivation of α-glucosidase by the active-site-directed inhibitor, conduritol B epoxide , 1985 .

[35]  Kevin Burgess,et al.  BODIPY dyes and their derivatives: syntheses and spectroscopic properties. , 2007, Chemical reviews.

[36]  Y. Hannun,et al.  Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. , 1989, The Journal of biological chemistry.

[37]  K. Umezawa,et al.  Production, isolation and structure determination of a novel beta-glucosidase inhibitor, cyclophellitol, from Phellinus sp. , 1990, The Journal of antibiotics.

[38]  H. Overkleeft,et al.  Glycosphingolipids--nature, function, and pharmacological modulation. , 2009, Angewandte Chemie.

[39]  G. Semenza,et al.  Partial amino acid sequences around the essential carboxylate in the active sites of the intestinal sucrase-isomaltase complex. , 1976, The Journal of biological chemistry.

[40]  O. Wolfbeis,et al.  Clickable fluorophores for biological labeling--with or without copper. , 2009, Organic & biomolecular chemistry.

[41]  Ronald R. Breaker,et al.  Kinetics of RNA Degradation by Specific Base Catalysis of Transesterification Involving the 2‘-Hydroxyl Group , 1999 .

[42]  P. Stahl,et al.  The structure and function of vertebrate mannose lectin-like proteins , 1988, Journal of Cell Science.

[43]  M. Langeveld,et al.  Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice , 2009, Hepatology.

[44]  N. Radin,et al.  Glucocerebrosidase: reconstitution of activity from macromolecular components. , 1973, The Biochemical journal.

[45]  J. Barranger,et al.  Function of oligosaccharide modification in glucocerebrosidase, a membrane-associated lysosomal hydrolase. , 1990, European journal of biochemistry.

[46]  Colleen N. Scott,et al.  pH-dependent Si-fluorescein hypochlorous acid fluorescent probe: spirocycle ring-opening and excess hypochlorous acid-induced chlorination. , 2013, Journal of the American Chemical Society.

[47]  Andrew G. Watts,et al.  Trypanosoma cruzi trans-sialidase operates through a covalent sialyl-enzyme intermediate: tyrosine is the catalytic nucleophile. , 2003, Journal of the American Chemical Society.

[48]  M. Nakata,et al.  A family of cyclophellitol analogs: synthesis and evaluation. , 1993, The Journal of antibiotics.

[49]  S. Withers,et al.  Cyclophellitol: a naturally occurring mechanism-based inactivator of beta-glucosidases. , 1991, Biochemical and biophysical research communications.

[50]  S. Withers,et al.  Approaches to labeling and identification of active site residues in glycosidases , 1995, Protein science : a publication of the Protein Society.

[51]  J. Alper Turning Sweet on Cancer , 2003, Science.

[52]  J. Lakowicz,et al.  Fluorescence properties of rhodamine 800 in whole blood and plasma. , 2000, Analytical biochemistry.

[53]  G. Semenza,et al.  Location of the two catalytic sites in intestinal lactase-phlorizin hydrolase. Comparison with sucrase-isomaltase and with other glycosidases, the membrane anchor of lactase-phlorizin hydrolase. , 1992, The Journal of biological chemistry.

[54]  R. Brady,et al.  Isolation and characterization of glucocerebrosidase from human placental tissue. , 1973, The Journal of biological chemistry.

[55]  R. Proia,et al.  Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[56]  S. Withers,et al.  Substituted glycals as probes of glycosidase mechanisms. , 1996, Bioorganic & medicinal chemistry.

[57]  R R Breaker,et al.  Characterization of a DNA-cleaving deoxyribozyme. , 2001, Bioorganic & medicinal chemistry.

[58]  R. Rogers,et al.  Distribution of murine mannose receptor expression from early embryogenesis through to adulthood , 1998, Cell and Tissue Research.

[59]  G. Legler,et al.  Amino acid sequence at the active site of β-glucosidase a from bitter almonds , 1978 .

[60]  N. White,et al.  Pharmacokinetic Properties ofAnti‐Influenza Neuraminidase Inhibitors , 2013, Journal of clinical pharmacology.

[61]  Kelley W. Moremen,et al.  Vertebrate protein glycosylation: diversity, synthesis and function , 2012, Nature Reviews Molecular Cell Biology.

[62]  V. Shepherd,et al.  Isolation and characterization of a mannose-specific endocytosis receptor from human placenta. , 1987, The Journal of biological chemistry.

[63]  B. Henrissat,et al.  Serratia marcescens chitobiase is a retaining glycosidase utilizing substrate acetamido group participation. , 1997, The Biochemical journal.

[64]  S. Withers,et al.  Unequivocal Identification of Asp-214 as the Catalytic Nucleophile of Saccharomyces cerevisiae -Glucosidase Using 5-Fluoro Glycosyl Fluorides , 1996, The Journal of Biological Chemistry.

[65]  R. Wolfenden,et al.  Spontaneous Hydrolysis of Glycosides , 1998 .

[66]  K. Umezawa,et al.  Accumulation of tissue glucosylsphingosine in Gaucher-like mouse induced by the glucosylceramidase inhibitor cyclophellitol. , 1993, Archives of Biochemistry and Biophysics.

[67]  D. Givol,et al.  Efficient in vitro and in vivo expression of human glucocerebrosidase cDNA. , 1987, DNA.

[68]  A. J. Bennet,et al.  Mutagenesis of the conserved active-site tyrosine changes a retaining sialidase into an inverting sialidase. , 2003, Biochemistry.

[69]  H. Overkleeft,et al.  Irreversible inhibitors and activity-based probes as research tools in chemical glycobiology. , 2011, Organic & biomolecular chemistry.

[70]  R. Molyneux,et al.  Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application , 2000 .

[71]  J. Barranger,et al.  Characterization of glucocerebrosidase in peripheral blood cells and cultured blastoid cells. , 1988, Experimental cell research.

[72]  S. Withers,et al.  Identification of glutamic acid 78 as the active site nucleophile in Bacillus subtilis xylanase using electrospray tandem mass spectrometry. , 1994, Biochemistry.

[73]  G. Legler Labelling of the active centre of a beta-glucosidase. , 1968, Biochimica et biophysica acta.

[74]  K. Handa,et al.  Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells , 2013, Proceedings of the National Academy of Sciences.

[75]  Brandi L. Cantarel,et al.  The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics , 2008, Nucleic Acids Res..

[76]  Hongyu Zhao,et al.  Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage , 2010, Proceedings of the National Academy of Sciences.

[77]  S. Withers,et al.  NMR spectroscopic characterization of a beta-(1,4)-glycosidase along its reaction pathway: stabilization upon formation of the glycosyl-enzyme intermediate. , 2007, Biochemistry.

[78]  G. Sinclair,et al.  Generation of a conditional knockout of murine glucocerebrosidase: utility for the study of Gaucher disease. , 2007, Molecular genetics and metabolism.

[79]  G. A. van der Marel,et al.  Ultrasensitive in situ visualization of active glucocerebrosidase molecules. , 2010, Nature chemical biology.

[80]  S. Withers,et al.  Insights into transition state stabilization of the β-1,4-glycosidase Cex by covalent intermediate accumulation in active site mutants , 1998, Nature Structural Biology.

[81]  J. M. Benito,et al.  Pharmacological chaperone therapy for Gaucher disease: a patent review , 2011, Expert opinion on therapeutic patents.

[82]  M. Bogyo,et al.  Tagging and detection strategies for activity-based proteomics. , 2007, Current opinion in chemical biology.

[83]  R. Desnick,et al.  Human acid beta-glucosidase: isolation and amino acid sequence of a peptide containing the catalytic site. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[84]  K. Hofmann,et al.  Iminobiotin affinity columns and their application to retrieval of streptavidin. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[85]  B. Henrissat,et al.  Identification of an essential glutamate residue in the active site of endoglucanase III from Trichoderma reesei , 1993, FEBS letters.

[86]  Richard L. Pederson,et al.  Enzyme-catalyzed aldol condensation for asymmetric synthesis of azasugars : synthesis, evaluation, and modeling of glycosidase inhibitors , 1991 .

[87]  S. Withers,et al.  Imaging of enzyme replacement therapy using PET , 2010, Proceedings of the National Academy of Sciences.

[88]  G. Legler,et al.  Identification of an essential carboxylate group at the active site of lacZ beta-galactosidase from Escherichia coli. , 1984, European journal of biochemistry.

[89]  H. Braun External yeast β-fructosidase. Affinity labeling of the active site , 1976 .

[90]  A. Vasella,et al.  Structural studies of the beta-glycosidase from Sulfolobus solfataricus in complex with covalently and noncovalently bound inhibitors. , 2004, Biochemistry.

[91]  Andrew G. Watts,et al.  Structural insights into the catalytic mechanism of Trypanosoma cruzi trans-sialidase. , 2004, Structure.

[92]  K. Nakao,et al.  Molecular cloning and expression of a novel klotho-related protein , 2000, Journal of Molecular Medicine.

[93]  B Henrissat,et al.  A classification of glycosyl hydrolases based on amino acid sequence similarities. , 1991, The Biochemical journal.

[94]  T. C. Bruice,et al.  Glycoside hydrolysis. II. Intramolecular carboxyl and acetamido group catalysis in beta-glycoside hydrolysis. , 1968, Journal of the American Chemical Society.

[95]  S. Withers,et al.  2-Deoxy-2-fluoroglucosides: a novel class of mechanism-based glucosidase inhibitors , 1987 .

[96]  Spencer J. Williams,et al.  Synthesis and Testing of Mechanism‐Based Protein‐Profiling Probes for Retaining Endo‐glycosidases , 2006, Chembiochem : a European journal of chemical biology.

[97]  K. Tatsuta Total synthesis and chemical design of useful glycosidase inhibitors , 1996 .

[98]  R. Laine,et al.  A calculation of all possible oligosaccharide isomers both branched and linear yields 1.05 x 10(12) structures for a reducing hexasaccharide: the Isomer Barrier to development of single-method saccharide sequencing or synthesis systems. , 1994, Glycobiology.

[99]  Ivone Carvalho,et al.  α- and β-Glucosidase inhibitors: chemical structure and biological activity , 2006 .

[100]  S. Withers,et al.  Mechanisms of enzymatic glycoside hydrolysis. , 1994, Current opinion in structural biology.

[101]  H. Overkleeft,et al.  Bioorthogonal chemistry: applications in activity-based protein profiling. , 2011, Accounts of chemical research.

[102]  A. Pastuszyn,et al.  Exolytic hydrolysis of toxic plant glucosides by guinea pig liver cytosolic beta-glucosidase. , 1992, The Journal of biological chemistry.

[103]  T. Berg,et al.  Extremely rapid endocytosis mediated by the mannose receptor of sinusoidal endothelial rat liver cells. , 1989, The Biochemical journal.

[104]  R H Glew,et al.  Enzyme loading of erythrocytes. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[105]  S. Withers,et al.  Glu280 is the nucleophile in the active site of Clostridium thermocellum CelC, a family A endo-beta-1,4-glucanase. , 1993, The Journal of biological chemistry.

[106]  S. Withers,et al.  Design and Synthesis of 2‘-Deoxy-2‘-Fluorodisaccharides as Mechanism-Based Glycosidase Inhibitors That Exploit Aglycon Specificity , 1997 .

[107]  S. Withers,et al.  Identification of the catalytic nucleophile in Family 42 β‐galactosidases by intermediate trapping and peptide mapping: YesZ from Bacillus subtilis , 2007, FEBS letters.

[108]  K. Umezawa,et al.  Inhibition of Experimental Metastasis by an α-Glucosidase Inhibitor, 1,6-Epi-cyclophellitol , 1993 .

[109]  L. Clarke,et al.  Transgenic mice expressing human glucocerebrosidase variants: utility for the study of Gaucher disease. , 2013, Blood cells, molecules & diseases.

[110]  W. Jencks,et al.  Reactions of anionic nucleophiles with .alpha.-D-glucopyranosyl fluoride in aqueous solution through a concerted, ANDN (SN2) mechanism , 1991 .

[111]  I. L. Arbeloa,et al.  Molecular forms of rhodamine B , 1981 .

[112]  H. Lieb Cerebrosidspeicherung bei Splenomegalie, Typus Gaucher , 1924 .

[113]  J. Rouvinen,et al.  Inversion of the roles of the nucleophile and acid/base catalysts in the covalent binding of epoxyalkyl xyloside inhibitor to the catalytic glutamates of endo-1,4-beta-xylanase (XYNII): a molecular dynamics study. , 2000, Protein engineering.

[114]  Carolyn R Bertozzi,et al.  A chemical approach for identifying O-GlcNAc-modified proteins in cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[115]  Jennifer A. Prescher,et al.  Rapid detection, discovery, and identification of post‐translationally myristoylated proteins during apoptosis using a bio‐orthogonal azidomyristate analog , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[116]  L. Dijkhuizen,et al.  Crystallographic Studies of the Interaction of Cyclodextrin Glycosyltransferase from Bacillus circulans Strain 251 with Natural Substrates and Products (*) , 1995, The Journal of Biological Chemistry.

[117]  N. Radin Treatment of Gaucher disease with an enzyme inhibitor , 1996, Glycoconjugate Journal.

[118]  G. Davies,et al.  Mapping the conformational itinerary of β-glycosidases by X-ray crystallography , 2003 .

[119]  R. Brady,et al.  Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease. , 1966, The Journal of clinical investigation.

[120]  J. Barranger,et al.  Glucocerebrosidase deficiency and lysosomal storage of glucocerebroside induced in cultured macrophages. , 1987, Experimental cell research.

[121]  N. Leslie,et al.  Enzyme therapy for Gaucher disease: the first 5 years. , 1998, Blood reviews.

[122]  Carolyn R Bertozzi,et al.  A strategy for functional proteomic analysis of glycosidase activity from cell lysates. , 2004, Angewandte Chemie.

[123]  Ronald R. Breaker,et al.  Catalytic DNA: in training and seeking employment , 1999, Nature Biotechnology.

[124]  J. M. Aerts,et al.  Demonstration of the existence of a second, non-lysosomal glucocerebrosidase that is not deficient in Gaucher disease. , 1993, Biochimica et biophysica acta.

[125]  F. Kreuzer,et al.  Difluorboryl‐Komplexe von Di‐ und Tripyrrylmethenen , 1968 .

[126]  G. Legler Glycoside hydrolases: mechanistic information from studies with reversible and irreversible inhibitors. , 1990, Advances in carbohydrate chemistry and biochemistry.

[127]  M. Sinnott,et al.  Catalytic mechanism of enzymic glycosyl transfer , 1990 .

[128]  M. Langeveld,et al.  Glycosphingolipids and insulin resistance. , 2009, Progress in lipid research.

[129]  G. Davies,et al.  Sorting the diverse: the sequence-based classifications of carbohydrate-active enzymes , 2008 .

[130]  S. Withers,et al.  NAG-thiazoline, An N-Acetyl-β-hexosaminidase Inhibitor That Implicates Acetamido Participation , 1996 .

[131]  G. Legler Untersuchungen zum Wirkungsmechanismus glykosidspaltender Enzyme, III. Markierung des aktiven Zentrums einer β-Glucosidase aus Aspergillus wentii mit [14C]Condurit-B-epoxid , 1968 .

[132]  C. Hollak,et al.  Biochemistry of glycosphingolipid storage disorders: implications for therapeutic intervention. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[133]  A. Khorlin,et al.  Specific irreversible inhibition of sweet-almond β-glucosidase by some β-glycopyranosylepoxyalkanes and β-d-glucopyranosyl isothiocyanate , 1976 .

[134]  M. Ho Identity of ‘acid’ β-glucosidase and glucocerebrosidase in human spleen , 1973 .

[135]  Yoram Tekoah,et al.  Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systems , 2013, Bioscience reports.

[136]  Guang Yang,et al.  Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity. , 2011, Advances in experimental medicine and biology.

[137]  Dedreia Tull,et al.  Crystallographic observation of a covalent catalytic intermediate in a β-glycosidase , 1996, Nature Structural Biology.

[138]  H. Overkleeft,et al.  Activity‐Based Profiling of Retaining β‐Glucosidases: A Comparative Study , 2011, Chembiochem : a European journal of chemical biology.

[139]  S. Withers,et al.  Positioning the acid/base catalyst in a glycosidase: studies with Bacillus circulans xylanase. , 1997, Biochemistry.

[140]  D. Brooks Getting into the fold. , 2007, Nature chemical biology.

[141]  K. Umezawa,et al.  Inhibition of glucocerebrosidase and induction of neural abnormality by cyclophellitol in mice. , 1992, Archives of biochemistry and biophysics.

[142]  E. Hehre A fresh understanding of the stereochemical behavior of glycosylases: structural distinction of "inverting" (2-MCO-type) versus "retaining" (1-MCO-type) enzymes. , 1999, Advances in carbohydrate chemistry and biochemistry.

[143]  W. Jencks,et al.  Reactions of Anionic Nucleophiles with α-D-Glucopyranosyl Fluoride in Aqueous Solution Through a Concerted, ANDN (SN2) Mechanism. , 1992 .

[144]  L. Cowart,et al.  Sphingolipid metabolism and analysis in metabolic disease. , 2011, Advances in experimental medicine and biology.

[145]  Ying Sun,et al.  Comparative Therapeutic Effects of Velaglucerase Alfa and Imiglucerase in a Gaucher Disease Mouse Model , 2010, PloS one.

[146]  R. Wolfenden,et al.  Spontaneous Hydrolysis of Ionized Phosphate Monoesters and Diesters and the Proficiencies of Phosphatases and Phosphodiesterases as Catalysts , 1998 .

[147]  N. Asano Glycosidase inhibitors: update and perspectives on practical use. , 2003, Glycobiology.

[148]  J. Moult,et al.  The identification by x-ray crystallography of the site of attachment of an affinity label to hen egg-white lysozyme. , 1973, Journal of molecular biology.

[149]  R. Brady,et al.  THE METABOLISM OF GLUCOCEREBROSIDES. I. PURIFICATION AND PROPERTIES OF A GLUCOCEREBROSIDE-CLEAVING ENZYME FROM SPLEEN TISSUE. , 1965, The Journal of biological chemistry.

[150]  A. Ballabio,et al.  Lysosomal disorders: from storage to cellular damage. , 2009, Biochimica et biophysica acta.

[151]  D. Witte,et al.  Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease. , 2003, The American journal of pathology.

[152]  Gary Lee,et al.  Pharmacological chaperones as therapeutics for lysosomal storage diseases. , 2013, Journal of medicinal chemistry.

[153]  R. Dwek,et al.  Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[154]  C. Sweeley,et al.  Glycosphingolipids of human KB cells grown in monolayer, suspension, and synchronized cultures. , 1975, The Journal of biological chemistry.

[155]  Alfred H. Merrill,et al.  Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics , 2011, Chemical reviews.

[156]  A. Bielawska,et al.  Role of Ceramide in Cellular Senescence (*) , 1995, The Journal of Biological Chemistry.

[157]  K. Iwabuchi,et al.  GM3-enriched Microdomain Involved in Cell Adhesion and Signal Transduction through Carbohydrate-Carbohydrate Interaction in Mouse Melanoma B16 Cells* , 1998, The Journal of Biological Chemistry.

[158]  S. Tsuji,et al.  Nucleotide sequence of cDNA containing the complete coding sequence for human lysosomal glucocerebrosidase. , 1986, The Journal of biological chemistry.

[159]  K. Umezawa,et al.  Biological activities of cyclophellitol. , 1990, The Journal of antibiotics.

[160]  R. Brady,et al.  Cerebroside synthesis in Gaucher's disease. , 1960, The Journal of clinical investigation.

[161]  M. Humphries,et al.  Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[162]  R. Brady,et al.  Lysosomal Storage Diseases , 1986, The Lancet.

[163]  H. Overkleeft,et al.  Triple bioorthogonal ligation strategy for simultaneous labeling of multiple enzymatic activities. , 2012, Angewandte Chemie.

[164]  Mario Maas,et al.  Substrate reduction therapy of glycosphingolipid storage disorders , 2006, Journal of Inherited Metabolic Disease.

[165]  R. Hammer,et al.  Mutation of beta-glucosidase 2 causes glycolipid storage disease and impaired male fertility. , 2006, The Journal of clinical investigation.

[166]  Y. Hannun,et al.  Programmed cell death induced by ceramide. , 1993, Science.

[167]  J. M. Aerts,et al.  Inhibition of Glycosphingolipid Synthesis Induces a Profound Reduction of Plasma Cholesterol and Inhibits Atherosclerosis Development in APOE*3 Leiden and Low-Density Lipoprotein Receptor−/− Mice , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[168]  Hongbin Yan,et al.  The synthesis and crystal structure of unsubstituted 4,4-difluoro-4-bora-3a,4a-diaza- s -indacene (BODIPY) , 2009 .

[169]  G. Semenza,et al.  Affinity labeling of the active sites in the sucrase-isomaltase complex from small intestine. , 1974, The Journal of biological chemistry.

[170]  J. M. Aerts,et al.  Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts. , 1987, European journal of biochemistry.

[171]  S. Withers,et al.  Glu-537, not Glu-461, is the nucleophile in the active site of (lac Z) beta-galactosidase from Escherichia coli. , 1992, The Journal of biological chemistry.

[172]  J. Norris,et al.  Interdiction of sphingolipid metabolism to improve standard cancer therapies. , 2013, Advances in cancer research.

[173]  U. Heinemann,et al.  Molecular and active-site structure of a Bacillus 1,3-1,4-beta-glucanase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[174]  E. Levy-Lahad,et al.  Replacement therapy with imiglucerase for type 1 Gaucher's disease , 1995, The Lancet.

[175]  S. Withers,et al.  Fluorinated and deoxygenated substrates as probes of transition-state structure in glycogen phosphorylase. , 1989, Biochemistry.

[176]  G. Davies,et al.  Structural basis for cyclophellitol inhibition of a β-glucosidase , 2007 .

[177]  S. Withers,et al.  Nature's many mechanisms for the degradation of oligosaccharides. , 2004, Organic & biomolecular chemistry.

[178]  P. Høj,et al.  Identification of glutamic acid 105 at the active site of Bacillus amyloliquefaciens 1,3-1,4-beta-D-glucan 4-glucanohydrolase using epoxide-based inhibitors. , 1992, The Journal of biological chemistry.

[179]  B. Oostra,et al.  Human lysosomal alpha-glucosidase. Characterization of the catalytic site. , 1991, The Journal of biological chemistry.

[180]  B. Ganem,et al.  A potent new class of active-site-directed glycosidase inactivators , 1988 .

[181]  Roger A. Laine,et al.  Invited Commentary: A calculation of all possible oligosaccharide isomers both branched and linear yields 1.05 × 1012 structures for a reducing hexasaccharide: the Isomer Barrier to development of single-method saccharide sequencing or synthesis systems , 1994 .

[182]  J. Dambrosia,et al.  Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. , 1991, The New England journal of medicine.

[183]  T. Cox,et al.  3 Gaucher's disease: clinical features and natural history , 1997 .

[184]  J. van Marle,et al.  Identification of the Non-lysosomal Glucosylceramidase as β-Glucosidase 2* , 2007, Journal of Biological Chemistry.

[185]  J. Kanfer,et al.  The Gaucher mouse. , 1975, Biochemical and biophysical research communications.

[186]  R. Spiro Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. , 2002, Glycobiology.

[187]  Eoin Fahy,et al.  Lipidomics reveals a remarkable diversity of lipids in human plasma1[S] , 2010, Journal of Lipid Research.

[188]  B. Torbett,et al.  A Chimeric Mouse Model of Gaucher Disease , 2002, Molecular medicine.

[189]  S. Withers,et al.  Breakdown of oligosaccharides by the process of elimination. , 2006, Current opinion in chemical biology.

[190]  S. M. Van Patten,et al.  Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease. , 2007, Glycobiology.

[191]  H. Mori,et al.  Chemical Modification and Amino Acid Sequence of Active Site in Sugar Beet α-Glucosidase , 1995 .

[192]  A. Clarke,et al.  Affinity labelling of Schizophyllum commune cellulase with [1-3H]-4,5-epoxypentyl β-cellobioside: synthesis of inhibitor and stoichiometry of interaction , 1989 .

[193]  J. M. Aerts,et al.  Iminosugar-Based Inhibitors of Glucosylceramide Synthase Increase Brain Glycosphingolipids and Survival in a Mouse Model of Sandhoff Disease , 2011, PloS one.

[194]  B Poole,et al.  Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[195]  Z. Dauter,et al.  Catalysis and specificity in enzymatic glycoside hydrolysis: a 2,5B conformation for the glycosyl-enzyme intermediate revealed by the structure of the Bacillus agaradhaerens family 11 xylanase. , 1999, Chemistry & biology.

[196]  A. K. Miller,et al.  Biotin-binding by parenterally-administered streptavidin or avidin. , 1964, Biochemical and biophysical research communications.

[197]  S. Morad,et al.  Ceramide-orchestrated signalling in cancer cells , 2012, Nature Reviews Cancer.

[198]  K. Sandhoff,et al.  LYSOSOMES AS STOMACHS OF THE CELL PROVIDE CELLS WITH NUTRIENTS , 2011 .

[199]  S. Withers,et al.  The synthesis, testing and use of 5-fluoro-α-d-galactosyl fluoride to trap an intermediate on green coffee bean α-galactosidase and identify the catalytic nucleophile , 2000 .

[200]  S. Withers,et al.  Structural and Biochemical Characterization of Glycoside Hydrolase Family 79 β-Glucuronidase from Acidobacterium capsulatum , 2012, The Journal of Biological Chemistry.

[201]  G. Semenza,et al.  Tryptic digestion of native small-intestinal sucrase - isomaltase complex: isolation of the sucrase subunit. , 1975, European journal of biochemistry.

[202]  L. Morales Gaucher's Disease: A Review , 1996, The Annals of pharmacotherapy.

[203]  M. Schwake,et al.  Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis , 2014, Journal of Lipid Research.

[204]  D. Vocadlo,et al.  Synthesis and use of mechanism-based protein-profiling probes for retaining beta-D-glucosaminidases facilitate identification of Pseudomonas aeruginosa NagZ. , 2008, Journal of the American Chemical Society.

[205]  P. Vogel,et al.  Glycosidase inhibitors as potential HIV entry inhibitors? , 2004, Current drug metabolism.

[206]  R. Brady,et al.  Enhanced macrophage uptake of synthetically glycosylated human placental beta-glucocerebrosidase. , 1982, The Journal of biological chemistry.

[207]  Lopatin De,et al.  Fluorescein. Hapten and antibody active-site probe , 1971 .

[208]  Huimin Ma,et al.  Spectroscopic probes with changeable π-conjugated systems. , 2012, Chemical communications.

[209]  F. Kiechle,et al.  Glycosphingolipids in Health and Disease , 2004 .

[210]  G. Legler Untersuchungen zum Wirkungsmechanismus glykosidspaltender Enzyme, V. Markierung des aktiven Zentrums der β-Glucosidasen A und B aus dem Süßmandel-Emulsin mit [3H]6-Brom-6-desoxy-condurit-B-epoxid , 1970 .

[211]  E. Galun,et al.  A Plant-Derived Recombinant Human Glucocerebrosidase Enzyme—A Preclinical and Phase I Investigation , 2009, PloS one.

[212]  N. Sharon,et al.  Chemical conversion of aspartic acid 52, a catalytic residue in hen egg-white lysozyme, to homoserine. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[213]  Ben Zhong Tang,et al.  The smallest and one of the brightest. Efficient preparation and optical description of the parent borondipyrromethene system. , 2009, The Journal of organic chemistry.

[214]  K. Schray,et al.  Active-site-directed inactivation of human liver α-l-fucosidase by conduritol C trans-epoxide , 1986 .

[215]  S. Withers,et al.  Identification of a covalent .alpha.-D-glucopyranosyl enzyme intermediate formed on a .beta.-glucosidase , 1988 .

[216]  G. Legler,et al.  Role of sugar hydroxyl groups in glycoside hydrolysis. Cleavage mechanism of deoxyglucosides and related substrates by beta-glucosidase A3 from Aspergillus wentii. , 1981, Biochimica et biophysica acta.

[217]  S. Withers,et al.  Crystallographic Evidence for Substrate-assisted Catalysis in a Bacterial β-Hexosaminidase* , 2001, The Journal of Biological Chemistry.

[218]  B. Henrissat,et al.  Mechanism-based inhibition and stereochemistry of glucosinolate hydrolysis by myrosinase. , 1996, Biochemistry.

[219]  E. Bause,et al.  Epoxyalkyl oligo-(1→4)-β-D-glucosides as active-site-directed inhibitors of cellulases , 1973 .

[220]  S. Withers,et al.  Mutagenesis of glycosidases. , 1999, Annual review of biochemistry.

[221]  B. Henrissat,et al.  Recent structural insights into the expanding world of carbohydrate-active enzymes. , 2005, Current opinion in structural biology.

[222]  Matthew S Macauley,et al.  O-GlcNAcase Uses Substrate-assisted Catalysis , 2005, Journal of Biological Chemistry.

[223]  D. G. Naumoff Hierarchical classification of glycoside hydrolases , 2011, Biochemistry (Moscow).

[224]  S. Karlsson,et al.  Murine models of acute neuronopathic Gaucher disease , 2007, Proceedings of the National Academy of Sciences.

[225]  R. Proia,et al.  Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage. , 2002, The Journal of clinical investigation.

[226]  P. Høj,et al.  Active site-directed inhibition by optically pure epoxyalkyl cellobiosides reveals differences in active site geometry of two 1,3-1,4-beta-D-glucan 4-glucanohydrolases. The importance of epoxide stereochemistry for enzyme inactivation. , 1991, The Journal of biological chemistry.

[227]  D. Kabelitz,et al.  Ceramide: does it matter for T cells? , 2002, Trends in immunology.

[228]  J. B. Kempton,et al.  Inactivation of a beta-glucosidase through the accumulation of a stable 2-deoxy-2-fluoro-alpha-D-glucopyranosyl-enzyme intermediate: a detailed investigation. , 1992, Biochemistry.

[229]  G. A. van der Marel,et al.  Novel activity-based probes for broad-spectrum profiling of retaining β-exoglucosidases in situ and in vivo. , 2012, Angewandte Chemie.

[230]  R. Brady,et al.  Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease. , 1974, The New England journal of medicine.

[231]  B. Henrissat,et al.  Stereochemistry of Chitin Hydrolysis by a Plant Chitinase/Lysozyme and X-ray Structure of a Complex with Allosamidin , 2001 .

[232]  E. Ginns,et al.  Glucocerebrosidase, a lysosomal enzyme that does not undergo oligosaccharide phosphorylation. , 1988, Biochimica et biophysica acta.

[233]  E. Ginns,et al.  Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene , 1992, Nature.

[234]  Richard D. Cummings,et al.  The repertoire of glycan determinants in the human glycome. , 2009, Molecular bioSystems.

[235]  Gregor Jung,et al.  Synthesis of the Core Compound of the BODIPY Dye Class: 4,4′-Difluoro-4-bora-(3a,4a)-diaza-s-indacene , 2009, Journal of Fluorescence.

[236]  R. Brady,et al.  METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE. , 1965, Biochemical and biophysical research communications.

[237]  Brady Ro,et al.  Investigations in enzyme replacement therapy in lipid storage diseases. , 1975 .

[238]  S. Withers,et al.  Mechanistic and Structural Analysis of a Family 31 α-Glycosidase and Its Glycosyl-enzyme Intermediate* , 2005, Journal of Biological Chemistry.

[239]  E. Stang,et al.  Endocytosis mediated by the mannose receptor in liver endothelial cells. An immunocytochemical study. , 1990, European journal of cell biology.

[240]  R. Brady,et al.  Investigations in enzyme replacement therapy in lipid storage diseases. , 1975, Federation proceedings.

[241]  Bernard Henrissat,et al.  High Resolution X-ray Crystallography Shows That Ascorbate Is a Cofactor for Myrosinase and Substitutes for the Function of the Catalytic Base* , 2000, The Journal of Biological Chemistry.

[242]  J. Rouvinen,et al.  Covalent binding of three epoxyalkyl xylosides to the active site of endo-1,4-xylanase II from Trichoderma reesei. , 1996, Biochemistry.

[243]  S. Withers,et al.  2-Deoxy-2-fluoro-D-glycosyl fluorides. A new class of specific mechanism-based glycosidase inhibitors. , 1988, The Journal of biological chemistry.

[244]  D. Witte,et al.  Gaucher disease mouse models: point mutations at the acid β-glucosidase locus combined with low-level prosaposin expression lead to disease variants Published, JLR Papers in Press, August 1, 2005. DOI 10.1194/jlr.M500202-JLR200 , 2005, Journal of Lipid Research.

[245]  E. Hehre Glycosyl transfer: a history of the concept's development and view of its major contributions to biochemistry. , 2001, Carbohydrate research.

[246]  R. Glew,et al.  The occurrence of beta-glucocerebrosidase activity in the glucocerebroside-rich deposits of Gaucher's disease. , 1974, Archives of biochemistry and biophysics.

[247]  M. Okuyama,et al.  Carboxyl group of residue Asp647 as possible proton donor in catalytic reaction of alpha-glucosidase from Schizosaccharomyces pombe. , 2001, European journal of biochemistry.

[248]  S. Withers,et al.  Identification of the Catalytic Nucleophile of the Family 29 α-L-Fucosidase from Thermotoga maritima through Trapping of a Covalent Glycosyl-Enzyme Intermediate and Mutagenesis* , 2003, Journal of Biological Chemistry.

[249]  A Bairoch,et al.  New families in the classification of glycosyl hydrolases based on amino acid sequence similarities. , 1993, The Biochemical journal.

[250]  S. Withers,et al.  Conduritol aziridine: a new mechanism-based glucosidase inactivator. , 1989, Biochemical and biophysical research communications.

[251]  S. Withers,et al.  Sugar ring distortion in the glycosyl-enzyme intermediate of a family G/11 xylanase. , 1999, Biochemistry.

[252]  B. Agranoff,et al.  Enzymic oxidation of cerebrosides: studies on Gaucher's disease. , 1962, Biochimica et biophysica acta.

[253]  S. Withers,et al.  Binding energy and catalysis. Fluorinated and deoxygenated glycosides as mechanistic probes of Escherichia coli (lacZ) beta-galactosidase. , 1992, The Biochemical journal.

[254]  S. Withers,et al.  Glycosidase mechanisms: anatomy of a finely tuned catalyst. , 1999, Accounts of chemical research.

[255]  S. Withers,et al.  Specificity Fingerprinting of Retaining β‐1,4‐Glycanases in the Cellulomonas fimi Secretome Using Two Fluorescent Mechanism‐Based Probes , 2007, Chembiochem : a European journal of chemical biology.